Company Active LTD

Company profile

Biofortuna Limited

Biofortuna Limited is a UK company with status active founded in 2008 based in North West England.

CRN
06514391
Founded
2008
Age
18

Overview

Legal name
BIOFORTUNA LIMITED
Region
North West England
Registered address
2 TENTH AVENUE
DEESIDE INDUSTRIAL PARK
DEESIDE
WALES
CH5 2UA
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 4
1
Company Active LTD
Biofortuna Limited
CRN 06514391
2
Direct and ultimate controller Active PLC

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
32

Company events

Reference milestones and recent Companies House filing stream events.

8 events
12 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

26 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

04 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzODQ1MjIyMmFkaXF6a2N4

Published 04 Oct 2024 04:34

04 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzODQ1MjE0M2FkaXF6a2N4

Published 04 Oct 2024 04:33

25 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNzIyMDE4MmFkaXF6a2N4

Published 25 Sep 2024 03:27

26 Feb
2008

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2013
Funded years
2013
Age at first award
5 years

Projects

2013 Feasibility Studies Lead participant

Novel automated capping system for molecular diagnostics

1 Apr 2013 to 30 Jun 2013

Awarded
£12,237
Total cost £16,316

Biofortuna is a molecular diagnostic company that develops products for the translation market and offers a contract manufacturing service based on their unique manufacturing process. Its ability to stabilize molecular diagnostic reagents at ambient temperatures for up to 18 months enables transportation, distribution and simplicity. The company faces a b...

Product types

Feasibility Studies